StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
49
This year
6
Publishing Date
2024 - 02 - 28
1
2024 - 02 - 08
1
2024 - 02 - 07
1
2024 - 01 - 19
1
2024 - 01 - 17
1
2024 - 01 - 16
1
2023 - 12 - 14
1
2023 - 11 - 28
1
2023 - 11 - 08
1
2023 - 10 - 27
1
2023 - 09 - 07
1
2023 - 08 - 31
1
2023 - 07 - 27
1
2023 - 07 - 26
1
2023 - 07 - 10
1
2023 - 06 - 06
1
2023 - 05 - 16
1
2023 - 05 - 02
1
2023 - 04 - 06
1
2023 - 04 - 03
1
2023 - 03 - 01
1
2022 - 12 - 14
1
2022 - 12 - 08
1
2022 - 11 - 18
1
2022 - 10 - 06
1
2022 - 05 - 27
1
2022 - 04 - 01
1
2022 - 03 - 31
1
2022 - 03 - 30
1
2022 - 03 - 15
1
2022 - 03 - 09
1
2022 - 03 - 01
1
2022 - 02 - 18
1
2021 - 11 - 24
1
2021 - 11 - 12
1
2021 - 11 - 03
1
2021 - 10 - 28
1
2021 - 09 - 23
1
2021 - 09 - 09
1
2021 - 09 - 07
1
2021 - 08 - 03
1
2021 - 07 - 29
1
2021 - 07 - 21
1
2021 - 07 - 02
1
2021 - 06 - 02
1
2021 - 03 - 04
1
2021 - 01 - 25
1
2021 - 01 - 20
1
2021 - 01 - 07
1
Sector
Commercial services
5
Finance
1
Health services
1
Health technology
48
Manufacturing
1
Retail trade
1
Technology services
2
Tags
Active
1
Al001
4
Al002
1
Al101
1
Als
1
Alzheimer
2
Alzheimer's
3
Alzheimer's disease
2
Alzheimer’s
5
Antibody
1
Biotechnology
3
Cancer
1
Collaboration
1
Companies
1
Conference
7
Dementia
7
Designation
1
Disease
5
Drug
1
Ema
1
Enroll
1
Fda
1
Financial
1
Financial results
2
First
1
Ftd-grn
2
Genetic
1
Genetown
1
Glioblastoma
1
Global
1
Grant
2
Granted
1
Grants
3
Growth
1
Health
1
Layoffs
2
Market
1
Meeting
1
Molecular
2
Monoclonal antibodies
1
N/a
40
Nasdaq
4
Neurodegenerative
1
Offering
3
Oncr-719
1
People
2
Phase 2
5
Pre-clinical
1
Preclinical
2
Progranulin gene
1
Progranulin gene mutation
1
Report
2
Research
2
Results
5
Sclerosis
1
Spac
1
Space
1
Thc
1
Therapy
2
Trial
4
Entities
Abbott laboratories
1
Abbvie inc.
1
Agios pharmaceuticals, inc.
1
Alector, inc.
43
Alphabet inc.
2
Aptinyx inc.
1
Axsome therapeutics, inc.
1
Biomarin pharmaceutical inc.
1
Biovie inc.
1
Bristol-myers squibb company
1
Cassava sciences, inc.
2
Centogene n.v.
5
Cepton inc
1
Coya therapeutics, inc.
1
Denali therapeutics inc.
2
Eli lilly and company
1
Gilead sciences, inc.
1
Glaxosmithkline plc
4
Hookipa pharma inc.
1
Ionis pharmaceuticals, inc.
1
Johnson & johnson
2
Longeveron llc - class a
1
Mesoblast limited
1
Morgan stanley
1
Morphosys ag
2
Nkarta, inc.
1
Novartis ag
1
Novavax, inc.
1
Oncorus, inc.
1
Passage bio, inc.
1
Prothena corporation plc
1
Renovacor, inc.
1
Sanofi
2
Seelos therapeutics, inc.
1
Therapeuticsmd, inc.
2
Vaxart, inc.
3
Walmart inc.
1
Symbols
ABBV
1
ABT
1
AGIO
1
ALEC
43
APTX
1
AXSM
1
BIVI
1
BMRN
1
BMY
1
CNTG
5
COYA
1
CPTN
1
DNLI
2
GILD
1
GOOG
2
GOOGL
2
GSK
4
HOOK
1
IONS
1
JNJ
2
LGVN
1
LLY
1
MESO
1
MOR
2
MPSYF
2
MS
1
NKTX
1
NVAX
1
NVS
1
NVSEF
1
ONCR
1
PASG
1
PRTA
1
RCOR
1
SAVA
2
SEEL
1
SNY
2
SNYNF
2
TXMD
2
VXRT
3
WMT
1
Exchanges
Nasdaq
49
Nyse
9
Crawled Date
2024 - 02 - 28
1
2024 - 02 - 08
1
2024 - 02 - 07
1
2024 - 01 - 19
1
2024 - 01 - 17
1
2024 - 01 - 16
1
2023 - 12 - 14
1
2023 - 11 - 28
1
2023 - 11 - 08
1
2023 - 10 - 27
1
2023 - 09 - 07
1
2023 - 08 - 31
1
2023 - 07 - 27
1
2023 - 07 - 26
1
2023 - 07 - 10
1
2023 - 06 - 06
1
2023 - 05 - 16
1
2023 - 05 - 02
1
2023 - 04 - 06
1
2023 - 04 - 03
1
2023 - 03 - 01
1
2022 - 12 - 14
1
2022 - 12 - 08
1
2022 - 11 - 18
1
2022 - 10 - 06
1
2022 - 05 - 27
1
2022 - 04 - 01
1
2022 - 03 - 31
1
2022 - 03 - 30
1
2022 - 03 - 15
1
2022 - 03 - 09
1
2022 - 03 - 01
1
2022 - 02 - 18
1
2021 - 11 - 24
1
2021 - 11 - 12
1
2021 - 11 - 03
1
2021 - 10 - 28
1
2021 - 09 - 23
1
2021 - 09 - 09
1
2021 - 09 - 07
1
2021 - 08 - 03
1
2021 - 07 - 29
1
2021 - 07 - 21
1
2021 - 07 - 02
1
2021 - 06 - 02
1
2021 - 03 - 04
1
2021 - 01 - 25
1
2021 - 01 - 20
1
2021 - 01 - 07
1
Crawled Time
11:00
6
12:00
9
12:06
1
12:30
1
13:00
1
13:20
2
14:00
5
14:15
2
14:20
1
14:30
2
15:00
1
18:00
1
19:00
1
21:00
8
22:00
6
22:01
1
23:00
1
Source
www.biospace.com
9
www.globenewswire.com
36
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
Flector
save search
Alector to Participate in Upcoming Healthcare Conferences
Published:
2024-02-28
(Crawled : 12:00)
- globenewswire.com
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-25.11%
|
O:
-0.14%
H:
8.25%
C:
-0.14%
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
Published:
2024-02-08
(Crawled : 12:00)
- globenewswire.com
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-2.76%
|
O:
-0.48%
H:
0.16%
C:
0.0%
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-17.97%
|
O:
0.0%
H:
2.34%
C:
-2.34%
al101
first
disease
alzheimer’s
trial
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
Published:
2024-02-07
(Crawled : 12:00)
- globenewswire.com
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-2.13%
|
O:
0.43%
H:
0.67%
C:
0.21%
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-13.08%
|
O:
2.15%
H:
5.51%
C:
3.73%
fda
dementia
designation
grants
therapy
Alector Announces Closing of Public Offering
Published:
2024-01-19
(Crawled : 14:30)
- globenewswire.com
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-9.01%
|
O:
-0.17%
H:
3.3%
C:
2.08%
offering
Alector Announces Pricing of Public Offering of Common Stock
Published:
2024-01-17
(Crawled : 14:00)
- globenewswire.com
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-31.28%
|
O:
-14.92%
H:
3.54%
C:
1.08%
offering
Alector Announces Proposed Public Offering of Common Stock
Published:
2024-01-16
(Crawled : 21:00)
- globenewswire.com
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-31.28%
|
O:
-14.92%
H:
3.54%
C:
1.08%
offering
Thinking about buying stock in Cepton Inc, Amtech Systems, Super Micro Computer, Upstart Holdings, or Alector?
Published:
2023-12-14
(Crawled : 14:30)
- prnewswire.com
CPTN
4
|
$3.0
-3.48%
11K
|
Manufacturing
|
-27.71%
|
O:
-26.45%
H:
5.14%
C:
0.0%
Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs
Published:
2023-11-28
(Crawled : 12:00)
- globenewswire.com
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
5.85%
|
O:
-0.4%
H:
5.47%
C:
4.45%
research
Alector to Participate in the Stifel Healthcare Conference
Published:
2023-11-08
(Crawled : 12:00)
- globenewswire.com
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-8.7%
|
O:
-3.48%
H:
0.0%
C:
-3.96%
conference
Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
Published:
2023-10-27
(Crawled : 11:00)
- globenewswire.com
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
14.52%
|
O:
-0.7%
H:
0.0%
C:
-2.46%
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-0.57%
|
O:
0.76%
H:
0.38%
C:
-3.57%
dementia
trial
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
Published:
2023-09-07
(Crawled : 11:00)
- globenewswire.com
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
14.97%
|
O:
0.13%
H:
1.95%
C:
1.89%
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-0.1%
|
O:
-1.24%
H:
10.79%
C:
8.09%
al002
disease
alzheimer’s
trial
Alector to Participate in Upcoming Healthcare Conferences
Published:
2023-08-31
(Crawled : 11:00)
- globenewswire.com
MS
|
News
0 d
|
$93.85
0.1%
0.0%
4.8M
|
Finance
|
9.51%
|
O:
-0.29%
H:
0.0%
C:
0.0%
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-7.08%
|
O:
0.35%
H:
1.59%
C:
-3.88%
Alector to Host Mid-Year Earnings Conference Call
Published:
2023-07-27
(Crawled : 12:00)
- globenewswire.com
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-17.45%
|
O:
-0.94%
H:
2.7%
C:
-1.83%
conference
Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and Company, Janssen, Merck, BioVie, Biogen, Vivoryon, Sage, Alnylam, BioXcel, EIP, Otsuka, Alector, Transposon
Published:
2023-07-26
(Crawled : 21:00)
- prnewswire.com
COYA
|
News
|
$8.28
3.24%
3.14%
120K
|
|
109.73%
|
O:
0.0%
H:
1.87%
C:
0.5%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
65.83%
|
O:
-0.06%
H:
1.18%
C:
0.37%
SEEL
|
$0.2971
-9.17%
-10.1%
600K
|
Health Technology
|
-77.78%
|
O:
1.48%
H:
0.73%
C:
-2.19%
PRTA
4
|
$20.59
0.15%
0.15%
340K
|
Health Technology
|
-67.0%
|
O:
1.08%
H:
2.08%
C:
1.79%
PASG
|
News
|
$1.27
3.25%
3.15%
39K
|
Health Technology
|
37.78%
|
O:
3.33%
H:
0.0%
C:
-8.82%
IONS
|
$42.455
1.47%
1.45%
730K
|
Health Technology
|
8.9%
|
O:
0.33%
H:
0.13%
C:
-1.56%
DNLI
|
$15.55
-3.48%
-3.6%
940K
|
Health Technology
|
-44.19%
|
O:
1.22%
H:
0.0%
C:
-1.42%
SAVA
M
|
$20.75
0.97%
0.96%
480K
|
Health Technology
|
3.49%
|
O:
0.6%
H:
1.74%
C:
1.24%
BIVI
|
$0.5025
2.18%
2.13%
850K
|
Health Technology
|
-89.13%
|
O:
0.43%
H:
0.85%
C:
-2.12%
AXSM
|
$71.23
-2.53%
-2.6%
580K
|
Health Technology
|
-6.6%
|
O:
0.56%
H:
3.6%
C:
0.99%
companies
active
dementia
market
ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs
Published:
2023-07-10
(Crawled : 14:00)
- biospace.com/
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-14.77%
|
O:
0.16%
H:
5.02%
C:
3.73%
therapeutics
Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
Published:
2023-06-06
(Crawled : 11:00)
- globenewswire.com
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-26.98%
|
O:
-1.67%
H:
5.52%
C:
4.95%
conference
global
CENTOGENE Reports Full Year 2022 Financial Results
Published:
2023-05-16
(Crawled : 22:00)
- globenewswire.com
CNTG
|
$0.475
-1.04%
-1.05%
19K
|
Commercial Services
|
-42.64%
|
O:
3.49%
H:
1.2%
C:
-3.61%
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-31.01%
|
O:
1.84%
H:
0.0%
C:
-1.68%
year
financial
results
Alector to Participate in the BofA Securities 2023 Healthcare Conference
Published:
2023-05-02
(Crawled : 11:00)
- globenewswire.com
ALEC
|
$5.27
-1.31%
-1.33%
380K
|
Health Technology
|
-21.41%
|
O:
-0.75%
H:
1.36%
C:
-3.62%
conference
BioSpace Layoff Tracker 2023: LumiraDx, Molecular Templates, Alector and More...
Published:
2023-04-06
(Crawled : 18:00)
- biospace.com/
VXRT
|
News
|
$0.7051
-5.41%
-5.72%
1.5M
|
Health Technology
|
-4.6%
|
O:
-1.63%
H:
2.66%
C:
0.6%
TXMD
|
News
|
$1.88
-0.27%
15K
|
Health Technology
|
-47.4%
|
O:
-0.82%
H:
2.76%
C:
-1.66%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
|
293.25%
|
O:
-2.83%
H:
11.21%
C:
10.99%
GOOGL
|
News
4
|
$159.18
0.58%
0.58%
22M
|
Technology Services
|
52.32%
|
O:
0.76%
H:
3.71%
C:
3.0%
GOOG
|
News
4
|
$161.05
0.71%
0.7%
19M
|
Technology Services
|
53.5%
|
O:
0.78%
H:
3.65%
C:
2.96%
molecular
BioSpace Layoff Tracker 2023: Molecular Templates, Alector, Applied Molecular Transport and More ...
Published:
2023-04-03
(Crawled : 14:00)
- biospace.com/
VXRT
|
News
|
$0.7051
-5.41%
-5.72%
1.5M
|
Health Technology
|
-6.17%
|
O:
0.0%
H:
3.08%
C:
0.0%
TXMD
|
News
|
$1.88
-0.27%
15K
|
Health Technology
|
-48.8%
|
O:
-2.4%
H:
4.64%
C:
1.37%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
|
355.81%
|
O:
-1.26%
H:
1.28%
C:
1.02%
GOOGL
|
News
4
|
$159.18
0.58%
0.58%
22M
|
Technology Services
|
53.41%
|
O:
-1.29%
H:
2.09%
C:
1.92%
GOOG
|
News
4
|
$161.05
0.71%
0.7%
19M
|
Technology Services
|
54.9%
|
O:
-1.28%
H:
2.22%
C:
2.18%
molecular
← Previous
1
2
3
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.